High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settings

•SARS-CoV-2 RT-PCR testing is central to follow disease spread.•Group testing expand testing capabilities but present some sensitivity concerns.•Digital PCR on group of 16 to 32 demonstrated similar sensitivity to individual RT-PCR.•Digital PCR reduced reagent needs, up to 80%, costs and increased t...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical virology Vol. 141; p. 104895
Main Authors Martin, Alexandra, Storto, Alexandre, Le Hingrat, Quentin, Collin, Gilles, André, Barbara, Mallory, Allison, Dangla, Rémi, Descamps, Diane, Visseaux, Benoit, Gossner, Olivier
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.08.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract •SARS-CoV-2 RT-PCR testing is central to follow disease spread.•Group testing expand testing capabilities but present some sensitivity concerns.•Digital PCR on group of 16 to 32 demonstrated similar sensitivity to individual RT-PCR.•Digital PCR reduced reagent needs, up to 80%, costs and increased testing capabilities. Worldwide demand for SARS-CoV-2 RT-PCR testing is still high as testing remains central to follow the disease spread and vaccine efficacy. Group testing has been proposed as a solution to expand testing capabilities but sensitivity concerns may limit its impact on the management of the pandemic. Digital PCR (RT-dPCR) has been shown to be highly sensitive and could help by providing larger testing capabilities without compromising sensitivity. We implemented RT-dPCR based COVID-19 group testing on a commercially available system and assay (naica® system from Stilla Technologies) and investigated the sensitivity of the method in real life conditions of a university hospital in Paris, France, in May 2020. We tested the protocol in a direct comparison with reference RT-PCR testing on 448 samples split into groups of 8, 16 and 32 samples for RT-dPCR analysis. Individual RT-PCR testing identified 25/448 positive samples. Using 56 groups of 8, RT-dPCR identified 23 groups as positive, corresponding to 26 positive samples by individual PCR (positive percentage agreement 95.2% [95% confidence interval: 76.2–99.9%]) and including 2 samples not detected by individual RT-PCR but confirmed positive by further investigation. 15 of 28 groups of 16 tested positive, corresponding to 25 positive samples by individual PCR (positive percentage agreement 87.5% [95% confidence interval: 61.7–98.4%]). 14 groups of 32 were fully concordant with individual PCR testing but will need to be confirmed on larger datasets. Our proposed approach of group testing by digital PCR has similar diagnostic sensitivity compared to individual RT-PCR testing for group up to 16 samples. This approach reduces the quantity of reagent needed by up to 80% while reducing costs and increasing capabilities of testing up to 10-fold.
AbstractList BACKGROUNDWorldwide demand for SARS-CoV-2 RT-PCR testing is still high as testing remains central to follow the disease spread and vaccine efficacy. Group testing has been proposed as a solution to expand testing capabilities but sensitivity concerns may limit its impact on the management of the pandemic. Digital PCR (RT-dPCR) has been shown to be highly sensitive and could help by providing larger testing capabilities without compromising sensitivity. METHODSWe implemented RT-dPCR based COVID-19 group testing on a commercially available system and assay (naica® system from Stilla Technologies) and investigated the sensitivity of the method in real life conditions of a university hospital in Paris, France, in May 2020. We tested the protocol in a direct comparison with reference RT-PCR testing on 448 samples split into groups of 8, 16 and 32 samples for RT-dPCR analysis. RESULTSIndividual RT-PCR testing identified 25/448 positive samples. Using 56 groups of 8, RT-dPCR identified 23 groups as positive, corresponding to 26 positive samples by individual PCR (positive percentage agreement 95.2% [95% confidence interval: 76.2-99.9%]) and including 2 samples not detected by individual RT-PCR but confirmed positive by further investigation. 15 of 28 groups of 16 tested positive, corresponding to 25 positive samples by individual PCR (positive percentage agreement 87.5% [95% confidence interval: 61.7-98.4%]). 14 groups of 32 were fully concordant with individual PCR testing but will need to be confirmed on larger datasets. CONCLUSIONSOur proposed approach of group testing by digital PCR has similar diagnostic sensitivity compared to individual RT-PCR testing for group up to 16 samples. This approach reduces the quantity of reagent needed by up to 80% while reducing costs and increasing capabilities of testing up to 10-fold.
•SARS-CoV-2 RT-PCR testing is central to follow disease spread.•Group testing expand testing capabilities but present some sensitivity concerns.•Digital PCR on group of 16 to 32 demonstrated similar sensitivity to individual RT-PCR.•Digital PCR reduced reagent needs, up to 80%, costs and increased testing capabilities. Worldwide demand for SARS-CoV-2 RT-PCR testing is still high as testing remains central to follow the disease spread and vaccine efficacy. Group testing has been proposed as a solution to expand testing capabilities but sensitivity concerns may limit its impact on the management of the pandemic. Digital PCR (RT-dPCR) has been shown to be highly sensitive and could help by providing larger testing capabilities without compromising sensitivity. We implemented RT-dPCR based COVID-19 group testing on a commercially available system and assay (naica® system from Stilla Technologies) and investigated the sensitivity of the method in real life conditions of a university hospital in Paris, France, in May 2020. We tested the protocol in a direct comparison with reference RT-PCR testing on 448 samples split into groups of 8, 16 and 32 samples for RT-dPCR analysis. Individual RT-PCR testing identified 25/448 positive samples. Using 56 groups of 8, RT-dPCR identified 23 groups as positive, corresponding to 26 positive samples by individual PCR (positive percentage agreement 95.2% [95% confidence interval: 76.2–99.9%]) and including 2 samples not detected by individual RT-PCR but confirmed positive by further investigation. 15 of 28 groups of 16 tested positive, corresponding to 25 positive samples by individual PCR (positive percentage agreement 87.5% [95% confidence interval: 61.7–98.4%]). 14 groups of 32 were fully concordant with individual PCR testing but will need to be confirmed on larger datasets. Our proposed approach of group testing by digital PCR has similar diagnostic sensitivity compared to individual RT-PCR testing for group up to 16 samples. This approach reduces the quantity of reagent needed by up to 80% while reducing costs and increasing capabilities of testing up to 10-fold.
Worldwide demand for SARS-CoV-2 RT-PCR testing is still high as testing remains central to follow the disease spread and vaccine efficacy. Group testing has been proposed as a solution to expand testing capabilities but sensitivity concerns may limit its impact on the management of the pandemic. Digital PCR (RT-dPCR) has been shown to be highly sensitive and could help by providing larger testing capabilities without compromising sensitivity. We implemented RT-dPCR based COVID-19 group testing on a commercially available system and assay (naica® system from Stilla Technologies) and investigated the sensitivity of the method in real life conditions of a university hospital in Paris, France, in May 2020. We tested the protocol in a direct comparison with reference RT-PCR testing on 448 samples split into groups of 8, 16 and 32 samples for RT-dPCR analysis. Individual RT-PCR testing identified 25/448 positive samples. Using 56 groups of 8, RT-dPCR identified 23 groups as positive, corresponding to 26 positive samples by individual PCR (positive percentage agreement 95.2% [95% confidence interval: 76.2-99.9%]) and including 2 samples not detected by individual RT-PCR but confirmed positive by further investigation. 15 of 28 groups of 16 tested positive, corresponding to 25 positive samples by individual PCR (positive percentage agreement 87.5% [95% confidence interval: 61.7-98.4%]). 14 groups of 32 were fully concordant with individual PCR testing but will need to be confirmed on larger datasets. Our proposed approach of group testing by digital PCR has similar diagnostic sensitivity compared to individual RT-PCR testing for group up to 16 samples. This approach reduces the quantity of reagent needed by up to 80% while reducing costs and increasing capabilities of testing up to 10-fold.
ArticleNumber 104895
Author Storto, Alexandre
André, Barbara
Descamps, Diane
Collin, Gilles
Mallory, Allison
Visseaux, Benoit
Dangla, Rémi
Le Hingrat, Quentin
Martin, Alexandra
Gossner, Olivier
Author_xml – sequence: 1
  givenname: Alexandra
  surname: Martin
  fullname: Martin, Alexandra
  organization: Stilla Technologies, Villejuif, France
– sequence: 2
  givenname: Alexandre
  surname: Storto
  fullname: Storto, Alexandre
  organization: Université de Paris, Assistance Publique – Hôpitaux de Paris, Service de virologie, Hôpital Bichat, Paris, France
– sequence: 3
  givenname: Quentin
  surname: Le Hingrat
  fullname: Le Hingrat, Quentin
  organization: Université de Paris, Assistance Publique – Hôpitaux de Paris, Service de virologie, Hôpital Bichat, Paris, France
– sequence: 4
  givenname: Gilles
  surname: Collin
  fullname: Collin, Gilles
  organization: Université de Paris, Assistance Publique – Hôpitaux de Paris, Service de virologie, Hôpital Bichat, Paris, France
– sequence: 5
  givenname: Barbara
  surname: André
  fullname: André, Barbara
  organization: Stilla Technologies, Villejuif, France
– sequence: 6
  givenname: Allison
  surname: Mallory
  fullname: Mallory, Allison
  organization: Stilla Technologies, Villejuif, France
– sequence: 7
  givenname: Rémi
  surname: Dangla
  fullname: Dangla, Rémi
  organization: Stilla Technologies, Villejuif, France
– sequence: 8
  givenname: Diane
  surname: Descamps
  fullname: Descamps, Diane
  organization: Université de Paris, Assistance Publique – Hôpitaux de Paris, Service de virologie, Hôpital Bichat, Paris, France
– sequence: 9
  givenname: Benoit
  orcidid: 0000-0002-9279-5538
  surname: Visseaux
  fullname: Visseaux, Benoit
  email: benoit.visseaux@aphp.fr
  organization: Université de Paris, Assistance Publique – Hôpitaux de Paris, Service de virologie, Hôpital Bichat, Paris, France
– sequence: 10
  givenname: Olivier
  surname: Gossner
  fullname: Gossner, Olivier
  organization: CNRS- CREST, Ecole Polytechnique, Palaiseau, France and London School of Economics, London, United Kingdom
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34246075$$D View this record in MEDLINE/PubMed
BookMark eNp9UU1r3DAUFCElX-0PyCXo2Iu3-rZNIBCWtCkEWpImVyHLz14ttuVK2oX999V209BeepH09GZGozfn6HjyEyB0ScmCEqo-rRdru10wwmiuRVXLI3RGq5IXslblcT7zShVKcnaKzmNcE0IlF-UJOuWCCUVKeYZW965fFRGm6JLburTDT7ePT8XSvxQM98FvZpwgJjf1uNnh1vUumQF_Xz5iM_p8GXfjnPxokrN4zitMKWI34ZWP829ohLRnx_foXWeGCB9e9wv0_Pnux_K-ePj25evy9qGwQtJU1FI2VDTZZ9Wy0jLgvFOKdEoa0yrBbCVs3VbE1lXTdJ2grQIOdVdyyG0g_ALdHHTnTTNCa7OhYAY9BzeasNPeOP1vZ3Ir3futrpjkSpZZ4OOrQPA_N_nvenTRwjCYCfwmaiYlYaqktcxQeoDa4GMM0L09Q4neJ6TXOiek9wnpQ0KZc_W3vzfGn0gy4PoAgDylrYOgo81jtdC6ADbp1rv_yP8CwFSlLQ
CitedBy_id crossref_primary_10_1063_5_0180394
crossref_primary_10_1128_cmr_00168_21
crossref_primary_10_1002_jcla_24178
crossref_primary_10_3390_jcm10235712
crossref_primary_10_2174_0113816128276560231218090436
crossref_primary_10_3389_fbioe_2022_837838
crossref_primary_10_1002_rmv_2471
Cites_doi 10.1373/clinchem.2013.211045
10.1101/2020.04.28.20074187
10.1214/aoms/1177731363
10.1093/ajcp/aqaa064
10.1101/2020.05.22.110932
10.1016/j.jcv.2020.104520
10.1038/s41586-019-1027-4
10.1001/jama.2020.5445
10.1373/clinchem.2014.230227
10.1016/S1473-3099(20)30362-5
10.1371/journal.pone.0055943
ContentType Journal Article
Copyright 2021 Elsevier Ltd
Copyright © 2021 Elsevier Ltd. All rights reserved.
2021 Elsevier B.V. All rights reserved. 2021 Elsevier Ltd
Copyright_xml – notice: 2021 Elsevier Ltd
– notice: Copyright © 2021 Elsevier Ltd. All rights reserved.
– notice: 2021 Elsevier B.V. All rights reserved. 2021 Elsevier Ltd
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1016/j.jcv.2021.104895
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1873-5967
EndPage 104895
ExternalDocumentID 10_1016_j_jcv_2021_104895
34246075
S1386653221001621
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29K
4.4
457
4CK
4G.
53G
5GY
5VS
7-5
71M
8P~
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABLVK
ABMAC
ABMZM
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AGEKW
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CJTIS
CS3
D-I
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HX~
HZ~
IHE
J1W
KOM
LCYCR
LUGTX
M41
MO0
N9A
O-L
O9-
OAUVE
OD-
OO.
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSI
SSZ
T5K
UNMZH
Z5R
~G-
AAXKI
ADVLN
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c451t-955b14b5348d27c2e33f660f65aad642c84c9d80c98bbff41d6e3e9f73ed64e03
IEDL.DBID AIKHN
ISSN 1386-6532
IngestDate Tue Sep 17 21:10:30 EDT 2024
Fri Aug 16 11:42:04 EDT 2024
Thu Sep 26 17:48:14 EDT 2024
Sat Sep 28 08:17:52 EDT 2024
Fri Feb 23 02:47:49 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords COVID-19
SARS-CoV-2
Digital PCR
Sample pooling
Group testing
RT-PCR
Language English
License Copyright © 2021 Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c451t-955b14b5348d27c2e33f660f65aad642c84c9d80c98bbff41d6e3e9f73ed64e03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-9279-5538
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8253657
PMID 34246075
PQID 2550267195
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8253657
proquest_miscellaneous_2550267195
crossref_primary_10_1016_j_jcv_2021_104895
pubmed_primary_34246075
elsevier_sciencedirect_doi_10_1016_j_jcv_2021_104895
PublicationCentury 2000
PublicationDate 2021-08-01
PublicationDateYYYYMMDD 2021-08-01
PublicationDate_xml – month: 08
  year: 2021
  text: 2021-08-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Journal of clinical virology
PublicationTitleAlternate J Clin Virol
PublicationYear 2021
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Yu, Yan, Wang, Yang, Wang, Tang, Gao, Wang, Ma, Xie, Wang, Tan, Zhu, Guo, Zhang (bib0015) 2020
Yelin, Aharony, Shaer Tamar, Argoetti, Messer, Berenbaum, Shafran, Kuzli, Gandali, Shkedi, Hashimshony, Mandel-Gutfreund, Halberthal, Geffen, Szwarcwort-Cohen, Kishony (bib0003) 2020
(bib0011) 2020
Strain, Lada, Luong, Rought, Gianella, Terry, Spina, Woelk, Richman (bib0012) 2013; 8
Hogan, Sahoo, Pinsky (bib0006) 2020; 323
Schmidt M., Hoehl S., Berger A., Zeichhardt H., Hourfar K., Ciesek S., Seifried E. 2020. FACT- Frankfurt adjusted COVID-19 testing- a novel method enables high-throughput SARS-CoV-2 screening without loss of sensitivity. medRxiv 2020.04.28.20074187.
(bib0010) 2020
Gupta, Abdul-Jawad, McCoy, Mok, Peppa, Salgado, Martinez-Picado, Nijhuis, Wensing, Lee, Grant, Nastouli, Lambert, Pace, Salasc, Monit, Innes, Muir, Waters, Frater, Lever, Edwards, Gabriel, Olavarria (bib0021) 2019; 568
Gollier, Gossner (bib0002) 2020
Dorfman (bib0001) 1943; 14
Griesemer, Van Slyke, St. George (bib0008) 2020
Anderson C., Castillo F., Koenig M., Managbanag J. 2020. Pooling nasopharyngeal swab specimens to increase testing capacity for SARS-CoV-2. bioRxiv 2020.05.22.110932.
Dingle, Sedlak, Cook, Jerome (bib0014) 2013; 59
Suo, Liu, Feng, Guo, Hu, Guo, Ullah, Yang, Zhang, Wang, Sajid, Huang, Deng, Chen, Liu, Xu, Liu, Zhang, Liu, Xiong, Chen, Lan, Chen (bib0017) 2020
Abdalhamid, Bilder, McCutchen, Hinrichs, Koepsell, Iwen (bib0007) 2020; 153
Lohse, Pfuhl, Berkó-Göttel, Rissland, Geißler, Gärtner, Becker, Schneitler, Smola (bib0009) 2020
Visseaux, Le Hingrat, Collin, Bouzid, Lebourgeois, Le Pluart, Deconinck, Lescure, Lucet, Bouadma, Timsit, Descamps, Yazdanpanah, Casalino, Houhou-Fidouh (bib0019) 2020
Vogels, Brito, Wyllie, Fauver, Ott, Kalinich, Petrone, Casanovas-Massana, Muenker, Moore, Klein, Lu, Lu-Culligan, Jiang, Kim, Kudo, Mao, Moriyama, Oh, Park, Silva, Song, Takehashi, Taura, Tokuyama, Venkataraman, Weizman, Wong, Yang, Cheemarla, White, Lapidus, Earnest, Geng, Vijayakumar, Odio, Fournier, Bermejo, Farhadian, Dela Cruz, Iwasaki, Ko, Landry, Foxman, Grubaugh (bib0020) 2020
Dong, Zhou, Niu, Wang, Pan, Sheng, Wang, Zhang, Yang, Liu, Zhao, Zhang, Zhu, Peng, Xie, Gao, Wang, Zhao, Dai, Fang (bib0016) 2020
Visseaux, Le Hingrat, Collin, Ferré, Storto, Ichou, Bouzid, Poey, de Montmollin, Descamps, Houhou-Fidouh (bib0018) 2020; 129
Huang, Liu, Wang, Xu, Yang, Shen, Liu, Zhou, Liu (bib0013) 2015; 61
Visseaux (10.1016/j.jcv.2021.104895_bib0019) 2020
Suo (10.1016/j.jcv.2021.104895_bib0017) 2020
Yelin (10.1016/j.jcv.2021.104895_bib0003) 2020
10.1016/j.jcv.2021.104895_bib0004
(10.1016/j.jcv.2021.104895_bib0011) 2020
Dingle (10.1016/j.jcv.2021.104895_bib0014) 2013; 59
Huang (10.1016/j.jcv.2021.104895_bib0013) 2015; 61
Gollier (10.1016/j.jcv.2021.104895_bib0002) 2020
Dorfman (10.1016/j.jcv.2021.104895_bib0001) 1943; 14
Yu (10.1016/j.jcv.2021.104895_bib0015) 2020
Gupta (10.1016/j.jcv.2021.104895_bib0021) 2019; 568
Griesemer (10.1016/j.jcv.2021.104895_bib0008) 2020
Vogels (10.1016/j.jcv.2021.104895_bib0020) 2020
Hogan (10.1016/j.jcv.2021.104895_bib0006) 2020; 323
Lohse (10.1016/j.jcv.2021.104895_bib0009) 2020
Strain (10.1016/j.jcv.2021.104895_bib0012) 2013; 8
Dong (10.1016/j.jcv.2021.104895_bib0016) 2020
(10.1016/j.jcv.2021.104895_bib0010) 2020
Abdalhamid (10.1016/j.jcv.2021.104895_bib0007) 2020; 153
Visseaux (10.1016/j.jcv.2021.104895_bib0018) 2020; 129
10.1016/j.jcv.2021.104895_bib0005
References_xml – volume: 323
  start-page: 1967
  year: 2020
  ident: bib0006
  article-title: Sample pooling as a strategy to detect community transmission of SARS-CoV-2
  publication-title: JAMA
  contributor:
    fullname: Pinsky
– year: 2020
  ident: bib0008
  article-title: Assessment of Sample Pooling for Clinical SARS-CoV-2 Testing
  contributor:
    fullname: St. George
– volume: 568
  start-page: 244
  year: 2019
  end-page: 248
  ident: bib0021
  article-title: HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
  publication-title: Nature
  contributor:
    fullname: Olavarria
– year: 2020
  ident: bib0020
  article-title: Analytical Sensitivity and Efficiency Comparisons of SARS-COV-2 qRT-PCR assays
  contributor:
    fullname: Grubaugh
– volume: 153
  start-page: 715
  year: 2020
  end-page: 718
  ident: bib0007
  article-title: Assessment of specimen pooling to conserve SARS CoV-2 testing resources
  publication-title: Am. J. Clin. Pathol.
  contributor:
    fullname: Iwen
– start-page: 58
  year: 2020
  ident: bib0019
  article-title: Evaluation of the QIAstat-Dx respiratory SARS-CoV-2 panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection
  publication-title: J. Clin. Microbiol.
  contributor:
    fullname: Houhou-Fidouh
– year: 2020
  ident: bib0009
  article-title: Pooling of samples for testing for SARS-CoV-2 in asymptomatic people
  publication-title: Lancet Infect. Dis.
  contributor:
    fullname: Smola
– start-page: ciaa345
  year: 2020
  ident: bib0015
  article-title: Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients
  publication-title: Clin. Infect. Dis.
  contributor:
    fullname: Zhang
– volume: 59
  start-page: 1670
  year: 2013
  end-page: 1672
  ident: bib0014
  article-title: Tolerance of Droplet-digital PCR vs real-time quantitative PCR to inhibitory substances
  publication-title: Clin. Chem.
  contributor:
    fullname: Jerome
– volume: 14
  start-page: 436
  year: 1943
  end-page: 440
  ident: bib0001
  article-title: The detection of defective members of large populations
  publication-title: Ann. Math. Stat.
  contributor:
    fullname: Dorfman
– year: 2020
  ident: bib0002
  article-title: Group Testing against COVID-19. 2020–04Working Papers
  contributor:
    fullname: Gossner
– volume: 61
  start-page: 290
  year: 2015
  end-page: 296
  ident: bib0013
  article-title: Next generation digital PCR measurement of hepatitis B virus copy number in formalin-fixed paraffin-embedded hepatocellular carcinoma tissue
  publication-title: Clin. Chem.
  contributor:
    fullname: Liu
– volume: 8
  start-page: e55943
  year: 2013
  ident: bib0012
  article-title: Highly precise measurement of HIV DNA by Droplet digital PCR
  publication-title: PLoS ONE
  contributor:
    fullname: Richman
– volume: 129
  year: 2020
  ident: bib0018
  article-title: Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection
  publication-title: J. Clin. Virol.
  contributor:
    fullname: Houhou-Fidouh
– year: 2020
  ident: bib0010
  article-title: Coronavirus SARS-CoV-2 : Poolage Des Tests RT-PCRRapport De l'HCSP
– start-page: 1
  year: 2020
  end-page: 30
  ident: bib0017
  article-title: ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens
  publication-title: Emerg Microbes Infect.
  contributor:
    fullname: Chen
– start-page: ciaa531
  year: 2020
  ident: bib0003
  article-title: Evaluation of COVID-19 RT-qPCR test in multi-sample pools
  publication-title: Clin. Infect. Dis.
  contributor:
    fullname: Kishony
– year: 2020
  ident: bib0011
  article-title: Coronavirus (COVID-19) Update: FDA Issues First Emergency Authorization for Sample Pooling in Diagnostic Testing
– year: 2020
  ident: bib0016
  article-title: Highly Accurate and Sensitive Diagnostic Detection of SARS-CoV-2 by Digital PCR
  contributor:
    fullname: Fang
– start-page: 1
  year: 2020
  ident: 10.1016/j.jcv.2021.104895_bib0017
  article-title: ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens
  publication-title: Emerg Microbes Infect.
  contributor:
    fullname: Suo
– volume: 59
  start-page: 1670
  year: 2013
  ident: 10.1016/j.jcv.2021.104895_bib0014
  article-title: Tolerance of Droplet-digital PCR vs real-time quantitative PCR to inhibitory substances
  publication-title: Clin. Chem.
  doi: 10.1373/clinchem.2013.211045
  contributor:
    fullname: Dingle
– year: 2020
  ident: 10.1016/j.jcv.2021.104895_bib0008
  contributor:
    fullname: Griesemer
– ident: 10.1016/j.jcv.2021.104895_bib0004
  doi: 10.1101/2020.04.28.20074187
– volume: 14
  start-page: 436
  year: 1943
  ident: 10.1016/j.jcv.2021.104895_bib0001
  article-title: The detection of defective members of large populations
  publication-title: Ann. Math. Stat.
  doi: 10.1214/aoms/1177731363
  contributor:
    fullname: Dorfman
– year: 2020
  ident: 10.1016/j.jcv.2021.104895_bib0010
– volume: 153
  start-page: 715
  year: 2020
  ident: 10.1016/j.jcv.2021.104895_bib0007
  article-title: Assessment of specimen pooling to conserve SARS CoV-2 testing resources
  publication-title: Am. J. Clin. Pathol.
  doi: 10.1093/ajcp/aqaa064
  contributor:
    fullname: Abdalhamid
– start-page: ciaa531
  year: 2020
  ident: 10.1016/j.jcv.2021.104895_bib0003
  article-title: Evaluation of COVID-19 RT-qPCR test in multi-sample pools
  publication-title: Clin. Infect. Dis.
  contributor:
    fullname: Yelin
– ident: 10.1016/j.jcv.2021.104895_bib0005
  doi: 10.1101/2020.05.22.110932
– year: 2020
  ident: 10.1016/j.jcv.2021.104895_bib0011
– start-page: ciaa345
  year: 2020
  ident: 10.1016/j.jcv.2021.104895_bib0015
  article-title: Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients
  publication-title: Clin. Infect. Dis.
  contributor:
    fullname: Yu
– volume: 129
  year: 2020
  ident: 10.1016/j.jcv.2021.104895_bib0018
  article-title: Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2020.104520
  contributor:
    fullname: Visseaux
– volume: 568
  start-page: 244
  year: 2019
  ident: 10.1016/j.jcv.2021.104895_bib0021
  article-title: HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
  publication-title: Nature
  doi: 10.1038/s41586-019-1027-4
  contributor:
    fullname: Gupta
– volume: 323
  start-page: 1967
  year: 2020
  ident: 10.1016/j.jcv.2021.104895_bib0006
  article-title: Sample pooling as a strategy to detect community transmission of SARS-CoV-2
  publication-title: JAMA
  doi: 10.1001/jama.2020.5445
  contributor:
    fullname: Hogan
– volume: 61
  start-page: 290
  year: 2015
  ident: 10.1016/j.jcv.2021.104895_bib0013
  article-title: Next generation digital PCR measurement of hepatitis B virus copy number in formalin-fixed paraffin-embedded hepatocellular carcinoma tissue
  publication-title: Clin. Chem.
  doi: 10.1373/clinchem.2014.230227
  contributor:
    fullname: Huang
– year: 2020
  ident: 10.1016/j.jcv.2021.104895_bib0016
  contributor:
    fullname: Dong
– start-page: 58
  year: 2020
  ident: 10.1016/j.jcv.2021.104895_bib0019
  article-title: Evaluation of the QIAstat-Dx respiratory SARS-CoV-2 panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection
  publication-title: J. Clin. Microbiol.
  contributor:
    fullname: Visseaux
– year: 2020
  ident: 10.1016/j.jcv.2021.104895_bib0002
  contributor:
    fullname: Gollier
– year: 2020
  ident: 10.1016/j.jcv.2021.104895_bib0009
  article-title: Pooling of samples for testing for SARS-CoV-2 in asymptomatic people
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(20)30362-5
  contributor:
    fullname: Lohse
– volume: 8
  start-page: e55943
  year: 2013
  ident: 10.1016/j.jcv.2021.104895_bib0012
  article-title: Highly precise measurement of HIV DNA by Droplet digital PCR
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0055943
  contributor:
    fullname: Strain
– year: 2020
  ident: 10.1016/j.jcv.2021.104895_bib0020
  contributor:
    fullname: Vogels
SSID ssj0015347
Score 2.411061
Snippet •SARS-CoV-2 RT-PCR testing is central to follow disease spread.•Group testing expand testing capabilities but present some sensitivity concerns.•Digital PCR on...
Worldwide demand for SARS-CoV-2 RT-PCR testing is still high as testing remains central to follow the disease spread and vaccine efficacy. Group testing has...
BACKGROUNDWorldwide demand for SARS-CoV-2 RT-PCR testing is still high as testing remains central to follow the disease spread and vaccine efficacy. Group...
SourceID pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 104895
SubjectTerms COVID-19
Digital PCR
Group testing
Hospitals
Humans
Pandemics
Polymerase Chain Reaction
RT-PCR
Sample pooling
SARS-CoV-2
Sensitivity and Specificity
Title High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settings
URI https://dx.doi.org/10.1016/j.jcv.2021.104895
https://www.ncbi.nlm.nih.gov/pubmed/34246075
https://search.proquest.com/docview/2550267195
https://pubmed.ncbi.nlm.nih.gov/PMC8253657
Volume 141
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbphkIvJX1m0zSo0FNBXct62cdladi0NJRsU3ITkixlHah3iZ3CXvrbq_Fj6bYlhx5tSyBm5NGI-eb7EHpreMiVKSQB8inCleMkN8aTQgRnpfXSOGhO_nwu55f845W42kOzoRcGYJV97O9iehut-zeT3pqTdVlOFpQBV1vckEAjJKGZfD8eR5yP0P707NP8fFtMEKzVGYPxBCYMxc0W5nXjfsRbYkqh2JmBysS_j6e_088_UZS_HUunB-hxn0_iabfkJ2jPV0_Rw05hcvMMLQHHQWpAqXcyEXgxvViQ2eobSXHb0YEb4NmorrHd4KK8Bg0R_GV2gVsVIlxvvq-bVUvrinsK1hqXFV72ciO49i1wun6OLk8_fJ3NSS-uQBwXtCG5EJZyG22TFalyqWcsSJkEKUx0HU9dxl1eZInLM2tD4LSQnvk8KObjZ5-wF2hUrSp_iHASrMidsiYpFPfK2Vz5mJlk1NBMGhvG6N1gU73uODT0AC670dEBGhygOweMER-srnc2go4x_r5pbwYP6fiDQNXDVH51V-t4ZwKVLQpjXnYe266C8ZTLmDSNkdrx5XYAkG_vfqnKZUvCHW_WTAp19H_LfYUewVOHJDxGo-b2zr-O2U1jT9CD9z_pSb-HfwFaC_un
link.rule.ids 230,315,786,790,891,4521,24144,27957,27958,45620,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEBbBobSX0nfcpwo9FYRXq9fu0ZgGp0lMiZOSm5C0UryBrk13U_C_r2Yfpm5LD72uJBAz2tGI-eb7EPpgeMiVKSQB8inCleMkN8aTQgRnpfXSOGhOPl_I-RX_fC2uD9Bs6IUBWGUf-7uY3kbr_sukt-ZkU5aTJWXA1RYPJNAISWgmP-RCUT5Ch9OT0_liV0wQrNUZg_kEFgzFzRbmdet-xFdiSqHYmYHKxN-vpz_Tz99RlL9cS8eP0MM-n8TTbsuP0YGvnqB7ncLk9ilaAY6D1IBS72Qi8HJ6sSSz9VeS4rajAzfAs1HdYLvFRXkDGiL4y-wCtypEuN5-2zTrltYV9xSsNS4rvOrlRnDtW-B0_QxdHX-6nM1JL65AHBe0IbkQlnIbbZMVqXKpZyxImQQpTHQdT13GXV5kicsza0PgtJCe-Two5uOwT9hzNKrWlT9COAlW5E5ZkxSKe-VsrnzMTDJqaCaNDWP0cbCp3nQcGnoAl93q6AANDtCdA8aID1bXewdBxxj_r2XvBw_p-INA1cNUfn1X6_hmApUtCnNedB7b7YLxlMuYNI2R2vPlbgKQb--PVOWqJeGOL2smhXr5f9t9h-7PL8_P9NnJ4vQVegAjHarwNRo13-_8m5jpNPZtf5J_AmpA_Zk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High-sensitivity+SARS-CoV-2+group+testing+by+digital+PCR+among+symptomatic+patients+in+hospital+settings&rft.jtitle=Journal+of+clinical+virology&rft.au=Martin%2C+Alexandra&rft.au=Storto%2C+Alexandre&rft.au=Le+Hingrat%2C+Quentin&rft.au=Collin%2C+Gilles&rft.date=2021-08-01&rft.pub=Elsevier+B.V&rft.issn=1386-6532&rft.eissn=1873-5967&rft.volume=141&rft_id=info:doi/10.1016%2Fj.jcv.2021.104895&rft.externalDocID=S1386653221001621
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1386-6532&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1386-6532&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1386-6532&client=summon